NeuroSense Therapeutics Ltd. Investing Cash Flow
NeuroSense Therapeutics Ltd. (NRSN) reported Investing Cash Flow of -$8.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-31
| Period end | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|
| 2025-12-31 | -$8.00K 20-F · filed 2026-03-31 | |
| 2025-06-30 | -$13.00K 6-K · filed 2025-08-01 | |
| 2024-12-31 | $1.00K 20-F · filed 2026-03-31 | |
| 2024-06-30 | $1.00K 6-K · filed 2025-08-01 | |
| 2023-12-31 | $3.47M 20-F · filed 2026-03-31 | |
| 2023-06-30 | $3.47M 6-K · filed 2024-09-30 | |
| 2022-12-31 | -$3.59M 20-F · filed 2025-04-07 | |
| 2021-12-31 | -$17.00K 6-K · filed 2024-06-17 |